• 1
    Centre for Health Statistics Institute. Selected Edition on the Health Statistics of China (1978–1990). Beijing : Ministry of Public Health, 1991; 789.
  • 2
    Parkin DM, Stjernsward J., Muir CS. Estimates of the worldwide frequency of twelve major cancers. Bull. World Health Organ. 1984; 62: 16382.
  • 3
    Yu SZ. Multivariate analysis in the causes of liver cancer. Chin. J. Prevent. Med. 1988; 22: 1969 (in Chinese).
  • 4
    Yu SZ, Liu PL, Huang JH. et al. The relationship between primary liver cancer and surface antigen of hepatitis B virus. Chin. J. Prevent. Med. 1986; 20: 911 (in Chinese).
  • 5
    Tabor E., Kabayash K. Hepatitis C virus, a causative infectious agent of non-A, non-B hepatitis. Prevalence and structure: Summary of a conference in HCV as a cause of hepatocellular carcinoma. J. Natl Cancer Inst. 1992; 84: 8690.
  • 6
    Zhao N., Yu SZ, Sun WM. Interaction among the relative risk factors of primary liver cancer. Chin. J. Epidem. 1994; 15: 903.
  • 7
    Yu SZ, Chen ZX, Liu NG et al. The aflatoxins and liver cancer in Guangxi, China. Chin. J. Prevent. Med. 1992; 26: 1624 (in Chinese).
  • 8
    Ross RK, Yuan JM, Yu MC et al. Urinary aflatoxin biomarkers and risk of hepatocellular carcinoma. Lancet 1992; 339: 9436.
  • 9
    Yin F., Yu SZ. The approach of aflatoxin adducts. Guo Wai Yi Xue (Hygiene) 1992; 5: 27981 (in Chinese).
  • 10
    Wild CP, Jansen LAM, Cova L. et al. Molecular dosimetry of aflatoxin exposure: Contribution to understanding the multifactorial etiopathogenesis of primary hepatocellular carcinoma with particular reference to hepatitis B virus. Environ. Health Perspectives 1993; 99: 15522.
  • 11
    Zhao YF, Yu SZ, Zhang MD. Relationship between levels of serum AFB1 adducts and levels of intake aflatoxin B1 in Guangxi Fusui County. Carcinogenesis, Teratogenesis and Mutagenesis 1993; 5: 1417 (in Chinese).
  • 12
    Zhao N., Yu SZ. The combined analysis of HCC prospective study about HBV and aflatoxins. Tumor 1994; 14: 22535 (in Chinese).
  • 13
    Zhou TL, Yu SZ. Laboratory study on the relationship between drinking water and hepatoma: Quantitative evaluation using GGT method. Chin. J. Prevent. Med. 1990; 24: 2035 (in Chinese).
  • 14
    Yu SZ, Chen G. Blue-green algae toxins and liver cancer. Chin. J. Cancer Res. 1994; 6: 917.
  • 15
    Kalengayi MMR et al. Histochemistry of gammaglutamyltranspeptidase in rat liver during aflatoxin B1 J. Natl Cancer Inst. 1975; 55: 597.
  • 16
    Zhang XM, Yu SZ, Sun J. The evaluation of primary prevention on primary liver cancer. J. Health Resource 1993; 2: 1923 (in Chinese).
  • 17
    Hsu IC, Metcalf RA, Sun T. et al. Mutational hotpot in the p53 gene in human hepatocellular carcinoma. Nature 1991; 350: 4278.
  • 18
    Bressac B., Kew M., Wands J. et al. Selective G to T mutations of p53 gene in hepatocellular carcinoma from southern Africa. Nature 1991; 350: 42931.
  • 19
    Ozturk M. p53 mutation in hepatocellular carcinoma after aflatoxin exposure. Lancet 1991; 338: 13569.
  • 20
    Fujiki H., Suganuma M. Tumour promotion by inhibitors of protein phosphatase 1 and 2A: The okadaic acid class of compound. Adv. Cancer Res. 1993; 61: 14394.
  • 21
    Himberg K., Keijola AM, Hiisvirta L. et al. The effect of water treatment processes on the removal of hepatoxins from Microcystis and Oscillatoria cyanobacteria: A laboratory study. Water Res. 1989; 23: 97984.
  • 22
    Liu PL, Dai SV, Yu SZ et al. The relationship between hepatitis B and primary liver cancer. J. China Public Health 1987; 6: 224 (in Chinese).
  • 23
    Zhang MD, Yu SZ, Liang RX et al. A population-based case control study of primary liver cancer in Fusui. Chin. J. Epidem. 1993; 14: 1418 (in Chinese).
  • 24
    IARC Monographs on the evaluation of carcinogenic risks to humans, Vol. 56. Some naturally occurring substances: food items and constituents, ferenocyclic aromatic amines and nycotoxins. 1993.